zofenopril

Small moleculeexperimental

Zofenopril (INN) is a medication that protects the heart and helps reduce high blood pressure. It is an angiotensin-converting enzyme (ACE) inhibitor. — Wikipedia

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
4

Earliest trial started Feb 1, 2016 (NCT02817360)

Timeline

No events for the selected filters.

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@@H](Sc2ccccc2)C[C@H]1C(=O)O
Mol. weight
429.56 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Prodrug

Sources

Also known as

  • l-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, (1(r*),2alpha,4alpha)-
  • menarini brand of zofenopril
  • sq 26900
  • sq-26900
  • sq 26991
  • sq-26991
  • sq-26991
  • sq. 26,991
  • zofenil
  • zofenil
  • zofenil
  • zofenopril
  • zofenopril
  • zofenopril
  • zofenopril
  • zofenopril
  • zofenopril
  • zofenopril
  • zofenopril
  • zofénopril
  • zofénopril
  • zofenopril calcium
  • zofenopril, calcium salt, (1(r*),2alpha,4alpha)-isomer
  • zofenopril potassium
  • zofenoprilum
  • zofenoprilum
  • zofil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05279807Phase 4Oct 15, 2021Menarini Group, University of Roma La Sapienza
NCT05257148Phase 4Apr 28, 2021Menarini Group, University of Roma La Sapienza
NCT04254042Phase 4Oct 1, 2018University of Yaounde
NCT02817360Phase 4Feb 1, 2016Medical University of Vienna, University of Vienna
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Menarini GroupFor profit2212021
University of Roma La SapienzaAcademic/Hospital2012021
Medical University of ViennaAcademic/Hospital1112016
University of ViennaAcademic/Hospital1012016
University of YaoundeAcademic/Hospital1112018
5 organizations
Page 1 / 1